PAH and phenylketonuria: Richards et al. also used AAV to deliver Cas9-mediated HDR editing system in to PKU mouse model and corrected the Pah point mutation in liver cells, partially restoring PAH activity and significantly reducing the level of blood phenylalanine [238].